Table 4 Genes supported as likely causal genes in decline-associated or stable-effect loci
Gene | Index variant: location (probability to be causal) | Index variant: functional consequence | Known phenotype | Locus type and novelty |
---|---|---|---|---|
Genes mapped to decline-associated loci | ||||
UMOD | Near/in gene (100%, 13%, 6%)a | eQTL(+) | Mendelianb | Novel 3rd signal |
TPPP | Nearest (90%) | eQTL(+) | Known decline | |
FGF5 | Nearest (49%) | eQTL(−) | Known decline | |
PRKAG2 | In gene (80%) | Mendelianc | Known decline | |
SDCCAG8 | In gene (22%) | Mendeliand | Novel decline | |
RRAGD | In gene (93%) | 5′ UTR | Mendeliane | Novel decline |
Genes mapped to stable-effect loci | ||||
CPS1 | In gene (100%) | Missense | Creatinine | Stable effect |
SLC22A2 | In gene (43%) | Creatinine | Stable effect | |
SLC34A1 | in gene (100%) | Mendelianf | Stable effect | |
UNCX | Nearest (61%) | eQTL(+) | Stable effect |